Harry G.M. Heijerman

机构：University Medical Center Utrecht · ORCID：0000-0002-8121-2843

发表论文 215 篇 · 总被引 11275 次 · h-index 42

代表论文

• Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials (2023 · The Lancet Respiratory Medicine · 被引 74)
• Measuring cystic fibrosis drug responses in organoids derived from 2D differentiated nasal epithelia (2022 · Life Science Alliance · 被引 54)
• Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients (2021 · Journal of Cystic Fibrosis · 被引 49)
• Non-respiratory health-related quality of life in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor (2022 · Journal of Cystic Fibrosis · 被引 44)
• CFTR Modulators: Does One Dose Fit All? (2021 · Journal of Personalized Medicine · 被引 34)
• The relation between psychological distress and medication adherence in lung transplant candidates and recipients: A cross‐sectional study (2021 · Journal of Clinical Nursing · 被引 28)